0.0390
-0.0140
(-26.42%)
Jun 18 - Close
OTCMKTS
data delayed by 15 mins -
Disclaimer
Currency in USD
| Range | 0.03 - 0.05 |
| 52 week | 0.03 - 0.25 |
| Open | 0.05 |
| Vol / Avg. | 149,342.00/112,207.00 |
| Mkt cap | 2.68M |
| P/E | - |
| Div/yield | - |
| EPS | -0.10 |
| Shares | 68.68M |
| Beta | 0.18 |
| Inst. own | - |
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | -126597.70% | -602042.90% |
| Operating margin | -123119.20% | -490863.00% |
| EBITD margin | - | -343666.40% |
| Return on average assets | -848.60% | -596.99% |
| Return on average equity | - | - |
| Employees | 4 | - |
| Carbon Disclosure Rating | - | - |
Address
3rd Floor, 670 Marina Drive
CHARLESTON, SC 29492
United States - Map
+1-843-9714848 (Phone)
+1-843-9716917 (Fax)
CHARLESTON, SC 29492
United States - Map
+1-843-9714848 (Phone)
+1-843-9716917 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
Revolutions Medical Corporation (Revolutions Medical) is principally engaged in the designing, developing and commercializing of retractable safety needle devices. Revolutions Medical is focused on developing and commercializing color Magnetic Resonance Imaging (MRI) technology. MRI is a widely used imaging system that safely creates many different and detailed views of selected portions of the internal anatomy. On February 22, 2009, the Company announced that it had received notification from the United States Food and Drug Administration (FDA) that the 510K application for the RevVac Safety Syringe has been approved.
Officers and directors
| Rondald L. Wheet | Chairman of the Board, Chief Executive Officer | |
| Burt Hodges | Chief Financial Officer | |
| Vincent Olmo | Chief Operating Officer | |
| Thomas M. Beahm M.D. | Independent Director |